Tufts’ Cohen Highlights ICER’s Third Value Assessment Framework

February 24, 2020

Tufts Medical Center’s Joshua Cohen, deputy director of the Center for the Evaluation of Value and Risk in Health, in a recent blog post spotlights the Institute for Clinical and Economic Review’s (ICER) third value assessment framework.

The latest framework, Cohen writes, opens the door for a social component in ICER’s assessments.

“It will be important for drug companies and other parties to help ensure ICER has the data needed to properly recognize and characterize societal benefits,” Cohen writes.

To read the full post, click here.

Share This Story!